Trilithium citrate tetrahydrate
Trilithium citrate tetrahydrate structure
|
Common Name | Trilithium citrate tetrahydrate | ||
|---|---|---|---|---|
| CAS Number | 6080-58-6 | Molecular Weight | 281.984 | |
| Density | N/A | Boiling Point | 309.6ºC at 760 mmHg | |
| Molecular Formula | C6H13Li3O11 | Melting Point | 112 °C | |
| MSDS | Chinese USA | Flash Point | 155.2ºC | |
|
Quantification of physiological amino acids by gradient ion-exchange high-performance liquid chromatography.
J. Chromatogr. A. 613 , 223, (1993) A single-column gradient lithium ion-exchange chromatographic method with post-column derivatization and fluorimetric detection for the quantification of physiological amino acids is described. The method runs automatically, requires a minimum of sample prepa... |
|
|
Lithium citrate for Canavan disease.
Pediatr. Neurol. 33 , 235-243, (2005) Current evidence suggests that the effects of lithium on metabolic and signaling pathways in the brain may vary depending on the specific clinical condition or disease model. For example, lithium increases levels of cerebral N-acetyl aspartate in patients wit... |
|
|
Lithium citrate as treatment of Canavan disease.
Clin. Neuropharmacol. 35 , 150-151, (2012) Canavan disease is a rare autosomal recessive leukodystrophy characterized by abnormal accumulation of N-acetyl aspartate (NAA) in brain white matter. Currently, there is no cure for this disease, and management of patients consists mainly of treating symptom... |
|
|
Treating PIK3CA and EGFR overexpressing breast cancers with lithium citrate.
Cancer Biol. Ther. 11 , 368-370, (2011)
|
|
|
Lithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease. Assadi M, Janson C, Wang DJ, et al.
Eur. J. Pediatr. 14 , 354-359, (2010)
|